Aquestive Therapeutics, Inc. (AQST) has a consensus analyst rating of Buy, based on 10 analysts covering the stock. Of those, 10 recommend buying, 0 recommend holding, and 0 recommend selling.
The analyst consensus price target for AQST is $10.00, representing a +141.0% upside from the current price of $4.15. Price targets range from a low of $6.00 to a high of $12.00.
